Quantitative Investment Management LLC Invests $528,000 in McKesson Corporation $MCK

Quantitative Investment Management LLC acquired a new position in shares of McKesson Corporation (NYSE:MCK) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 700 shares of the company’s stock, valued at approximately $528,000.

Several other institutional investors and hedge funds have also modified their holdings of MCK. University of Texas Texas AM Investment Management Co. bought a new position in McKesson in the fourth quarter valued at about $25,000. Swiss RE Ltd. bought a new stake in shares of McKesson during the 4th quarter valued at approximately $26,000. Delos Wealth Advisors LLC bought a new stake in shares of McKesson during the 2nd quarter valued at approximately $27,000. State of Wyoming acquired a new position in McKesson during the 2nd quarter worth approximately $29,000. Finally, Kingdom Financial Group LLC. acquired a new position in McKesson during the 4th quarter worth approximately $33,000. 85.07% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Evercore restated an “outperform” rating on shares of McKesson in a research report on Thursday, August 6th. Wall Street Zen downgraded shares of McKesson from a “buy” rating to a “hold” rating in a report on Saturday, June 27th. TD Cowen increased their price target on McKesson from $989.00 to $1,006.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $875.00 price objective on shares of McKesson in a report on Friday, May 8th. Finally, Royal Bank Of Canada started coverage on McKesson in a research report on Wednesday, August 19th. They set a “sector perform” rating and a $845.00 price objective on the stock. Fourteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $973.44.

Key McKesson News

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: Market resilience despite the breach headlines: McKesson’s shares remained higher, suggesting investors may be viewing the incident as manageable for now. The company’s latest reported quarter showed revenue growth, earnings above estimates and fiscal 2027 EPS guidance of $44.20–$45.00, although those results predate the cybersecurity disclosures.
• Neutral Sentiment: Long-term performance remains a supportive backdrop: A separate report highlights the substantial wealth created by holding McKesson over the past decade. However, the article is retrospective and does not provide a new reason for near-term buying. Here’s How Much a $1000 Investment in McKesson Made 10 Years Ago Would Be Worth Today
• Negative Sentiment: McKesson confirmed a cybersecurity incident involving data exfiltration. The company is investigating what information was accessed or removed. Several reports say the attackers, identified as the ShinyHunters group, claim to have stolen as many as 284 million patient records; McKesson has not confirmed that figure or the full scope of the affected data. McKesson confirms cyberattack as hackers claim theft of patient data Hackers claim millions of patient records stolen during data breach at healthcare giant McKesson
• Negative Sentiment: Potential financial and operational consequences are significant. McKesson supplies roughly one-third of hospital prescriptions, increasing the sensitivity of any disruption. Reports also cite an alleged $55 million ransom demand and threats to publish stolen information. Possible effects include incident-response costs, regulatory scrutiny, lawsuits, customer remediation and reputational damage, though the ransom amount and breach size remain unverified. McKesson Faces $55 Million Ransom Demand After Massive Data Breach McKesson investigating cybersecurity incident

McKesson Stock Performance

MCK stock opened at $907.95 on Wednesday. The company has a fifty day moving average price of $838.95 and a 200-day moving average price of $842.64. The company has a market capitalization of $105.86 billion, a P/E ratio of 24.30, a PEG ratio of 1.74 and a beta of 0.30. McKesson Corporation has a 52-week low of $682.35 and a 52-week high of $999.00.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, August 5th. The company reported $9.93 EPS for the quarter, beating the consensus estimate of $9.56 by $0.37. The business had revenue of $105.38 billion for the quarter, compared to analysts’ expectations of $103.88 billion. McKesson had a negative return on equity of 253.21% and a net margin of 1.12%.The firm’s revenue was up 7.7% on a year-over-year basis. During the same period in the prior year, the business posted $8.26 earnings per share. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. As a group, sell-side analysts forecast that McKesson Corporation will post 44.65 earnings per share for the current fiscal year.

McKesson Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Tuesday, September 1st will be given a dividend of $0.94 per share. This represents a $3.76 annualized dividend and a dividend yield of 0.4%. This is a boost from McKesson’s previous quarterly dividend of $0.82. The ex-dividend date is Tuesday, September 1st. McKesson’s dividend payout ratio is currently 10.06%.

Insider Transactions at McKesson

In other McKesson news, CEO Brian S. Tyler sold 8,463 shares of the company’s stock in a transaction on Tuesday, July 7th. The shares were sold at an average price of $793.56, for a total transaction of $6,715,898.28. Following the sale, the chief executive officer owned 5,919 shares of the company’s stock, valued at approximately $4,697,081.64. This represents a 58.84% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bradley E. Lerman sold 301 shares of the stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $892.33, for a total value of $268,591.33. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 22,289 shares of company stock worth $17,406,854 over the last three months. 0.06% of the stock is owned by company insiders.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.